| Recruiting | 1/2 | 144 | US | AVM0703, Supra-Pharmacologic Dexamethasone Phosphate | AVM Biotechnology Inc, Medpace, Inc. | Lymphoid Malignancies | 04/25 | 06/25 | | |
| Not yet recruiting | 1 | 16 | NA | AVM0703, Suprapharmacologic dexamethasone sodium phosphate, Placebo | AVM Biotechnology LLC, Medpace, Inc. | ARDS, Covid19, Influenza, Human | 12/24 | 03/25 | | |
NCT05974410: Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients |
|
|
| Available | N/A | | NA | AVM0703, Hydrocortisone, Proton pump inhibitor | AVM Biotechnology Inc | Glioblastoma, Squamous Cell Carcinoma, Hodgkin Lymphoma, Non-hodgkin Lymphoma, Breast Cancer, Prostate Cancer, Gastric Cancer, Ovarian Cancer, Acute Leukemia, Pancreatic Cancer, Spindle Cell Sarcoma, Cancer, Tumor, Solid, Tumor, Brain | | | | |